Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer.
Ala Litman-ZawadzkaMarta Łukaszewicz-ZającMariusz GrykoAgnieszka Kulczyńska-PrzybikBogusław KędraBarbara MroczkoPublished in: International journal of molecular sciences (2020)
CXCR4 is a better candidate for a tumor marker than CXCR2 in the diagnosis of PC, while serum CXCR2 is a significant predictor of PC risk.
Keyphrases